Image

A PRPCT to Assess the Efficacy & Safety of Chronic Pain Rehab Training Software for Alleviating Chronic Secondary Musculoskeletal Pain

A PRPCT to Assess the Efficacy & Safety of Chronic Pain Rehab Training Software for Alleviating Chronic Secondary Musculoskeletal Pain

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

A prospective, randomized, parallel-controlled clinical trial to evaluate the effectiveness and safety of chronic pain rehabilitation training software in assisting in the relief of chronic secondary musculoskeletal pain

Description

A PRPCT to assess the efficacy & safety of chronic pain rehab training software for alleviating chronic secondary musculoskeletal pain

Eligibility

Inclusion Criteria:

  • Males and females ≥18 years old.
  • Average pain intensity≥4 on a 0-10 numerical rating scale (NRS) in the past 24 hours.
  • Be able to communicate in Chinese.
  • Be able to read and write Chinese.
  • Willing to comply with study procedures and restrictions.
  • Willing and able to sign informed consent.

Exclusion Criteria:

  • Shingles on the eyes, ears, head, face, or hands.
  • Trigeminal neuralgia.
  • Severe vision impairment. (Patients with clear vision wearing glasses or contact lenses are allowed)
  • Severe hearing impairment.
  • Disease or medical condition predisposing to nausea or dizziness, such as insufficient blood supply to the brain, vestibular dysfunction,cholecystitis, etc.
  • History of severe motion sickness.
  • Injury to eyes, ears, face, or neck that impedes comfortable use of mixed reality.
  • Injury or dysfunction of hands or upper limbs that impedes comfortable use of mixed reality.
  • Diagnosis of cognitive impairment, epilepsy, dementia, migraines or other neurological diseases that may prevent the use of mixed reality.
  • History of mental illness, including depression, generalized anxiety disorder, schizophrenia, etc.
  • Females currently pregnant.
  • Current or completion of participation within 4 weeks before screening in any interventional clinical study
  • Patients whom the investigator considers not suitable to participate in this study.

Study details
    Chronic Pain

NCT06936059

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

26 April 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.